dopaminergic neuronal precursor cells | Search

Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

49,883 results for “dopaminergic neuronal precursor cells”

Trials

View all 35485 →

Evaluation of Safety and Tolerability of Fetal Mesencephalic Dopamine Neuronal Precursor Cells for Parkinson's Disease

15 participants · First posted May 23, 2013

A Clinical Trial of Parkinson's Disease Treatment by HiPSCs Derived Dopaminergic Neural Precursor Cells

3 participants · First posted Nov 24, 2023

A Trial to Evaluate the Safety, Tolerability and Preliminary Efficacy of NCR201 in the Treatment of Subjects With Parkinson's Disease

48 participants · First posted May 18, 2025

Drugs

View all 4173 →

Allogeneic dopaminergic neural precursor cell

Human dopaminergic precursor (Wuhan Ruijian)

autologous muscle precursor cells

Organizations

View all 83 →

STEM CELLS ARABIA

Jordan

Personalized Stem Cells, Inc.

United States

KLSMC Stem Cells, Inc.

News

View all 10142 →

Aspen Neuroscience Advances Commercial-Ready Parkinson's Cell Therapy in Phase 1/2a Trial

Aspen Neuroscience's ANPD001 Shows Promise in Early Parkinson's Trial

Cerevance Reports Positive Phase 2 Results for Novel Non-Dopaminergic Parkinson's Treatment Solengepras

Page 1 of 4989